Abstract | OBJECTIVES: To analyze the expression and potential role of interleukin (IL) 21 in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease. METHODS: RESULTS: The results showed a significantly increased serum IL-21 level, as well as higher IL-21 mRNA expression by PBMCs, in patients having chronic or recurrent active VKH disease compared with patients having inactive VKH disease and with controls. In vitro experiments showed that recombinant IL-21 significantly increased IL-17 production by PBMCs and by CD4(+) T cells from patients and from controls. However, recombinant IL-21 did not affect interferon γ expression by PBMCs or by CD4(+) T cells. CONCLUSION:
Interleukin 21 may be involved in the pathogenesis of chronic or recurrent VKH disease, possibly by promoting IL-17 secretion. CLINICAL RELEVANCE: Findings from the present study suggest that IL-21 may be a potential target in the development of therapy for VKH disease.
|
Authors | Fuzhen Li, Peizeng Yang, Xiaoli Liu, Chaokui Wang, Shengping Hou, Aize Kijlstra |
Journal | Archives of ophthalmology (Chicago, Ill. : 1960)
(Arch Ophthalmol)
Vol. 128
Issue 11
Pg. 1449-54
(Nov 2010)
ISSN: 1538-3601 [Electronic] United States |
PMID | 21060047
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Interleukin-17
- Interleukins
- RNA, Messenger
- Recombinant Proteins
- Interferon-gamma
- interleukin-21
|
Topics |
- Adult
- CD4-Positive T-Lymphocytes
(drug effects, metabolism)
- Cells, Cultured
- Chronic Disease
- Enzyme-Linked Immunosorbent Assay
- Female
- Gene Expression Regulation
(physiology)
- Humans
- Interferon-gamma
(metabolism)
- Interleukin-17
(biosynthesis)
- Interleukins
(blood, genetics, pharmacology)
- Leukocytes, Mononuclear
(drug effects, metabolism)
- Male
- RNA, Messenger
(genetics)
- Recombinant Proteins
(pharmacology)
- Recurrence
- Reverse Transcriptase Polymerase Chain Reaction
- Uveomeningoencephalitic Syndrome
(genetics, metabolism)
|